# A Study of LP-128 Capsules in Healthy Subjects

> **NCT05130567** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Guangzhou Lupeng Pharmaceutical Company LTD.** · enrollment: 104 (estimated)

## Conditions studied

- Chronic Hepatitis b

## Interventions

- **DRUG:** LP-128 capsules
- **OTHER:** Matching Placebo

## Key facts

- **NCT ID:** NCT05130567
- **Lead sponsor:** Guangzhou Lupeng Pharmaceutical Company LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-11-19
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05130567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05130567, "A Study of LP-128 Capsules in Healthy Subjects". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05130567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*